Maxim Group downgraded Galena Biopharma (NASDAQ: GALE) from Buy to Hold.Analyst Jason McCarthy highlighted:Upon the announcement of Galena's CEO Dr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE